Organizations across the country — even globally — are taking a hard look at their imaging ecosystems and determining it is time for change. Most technology and clinical leaders have read, listened to and observed the imaging vendor narrative over the past few years while they focused primarily on deploying the electronic health records (HER). Now most feel comfortable enough — either internally or with the help of consultants — to tackle this next huge patient record initiative. Vendor neutral archives (VNA), viewers, workflow, analytics, integration and exchange are all under review as components of the enterprise imaging effort. The good news for those in this phase of discovery and analysis is that the pioneers are far enough down the path to prove that an enterprise approach can be incredibly successful and that there are organizational, clinical, technical and even financial benefits to adopting this model.  


Check-Cap Ltd. recently announced the enrollment of the first patient in its multi-center study of the C-Scan system in support of its CE Mark submission.

January 31, 2017 — CereScan has increased its functional brain diagnostics network with the addition of Northwest Community Healthcare (NCH) in Arlington Heights, Ill. Patients in the Midwest region who are suffering from lingering head and brain injuries may now use the software designed to statistically measure brain diagnostics to understand the biological basis of their symptoms for a more direct path to treatment and recovery.

Sectra announced that John Muir Health has purchased an archive to store radiology and cardiology studies in the cloud. All images in the enterprise will be archived in three geographically separate areas with fail-over capabilities. Integration with the Epic EMR (electronic medical record) will allow physicians to access comprehensive patient records through the Sectra Universal Viewer.

World Congress on Radiology and Oncology

Directors of radiologic technology educational programs report that the number of students enrolling in radiography and nuclear medicine programs increased slightly in 2016, while radiation therapy programs saw a slight decline.

The Department of Human Oncology at the University of Wisconsin-Madison has chosen RayStation as its next radiation therapy treatment planning system. The agreement was signed in late December 2016, and the purchase is planned to occur in two phases.

Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney injury, despite long-held fears to the contrary. The results of the largest controlled study of acute kidney injury following contrast media administration in the emergency department were published online in Annals of Emergency Medicine ("Risk of Acute Kidney Injury Following Intravenous Contrast Media Administration").

Subscribe Now